Protia (XKRX:303360) Debt-to-Equity : 0.01 (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Protia Debt-to-Equity?

Protia's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩103 Mil. Protia's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩119 Mil. Protia's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩26,207 Mil. Protia's debt to equity for the quarter that ended in Dec. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Protia's Debt-to-Equity or its related term are showing as below:

XKRX:303360' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.05 Med: 0.02 Max: 0.18
Current: 0.01

During the past 7 years, the highest Debt-to-Equity Ratio of Protia was 0.18. The lowest was -0.05. And the median was 0.02.

XKRX:303360's Debt-to-Equity is ranked better than
99.47% of 189 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs XKRX:303360: 0.01

Protia Debt-to-Equity Historical Data

The historical data trend for Protia's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protia Debt-to-Equity Chart

Protia Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.18

0.02

0.01

Protia Quarterly Data
	Dec18	Dec19	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial										0.01	0.01	0.01	-	0.01

Competitive Comparison of Protia's Debt-to-Equity

For the Diagnostics & Research subindustry, Protia's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protia's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Protia's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Protia's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Protia Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Protia's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(102.534	+	118.933)	/	26207.201
	=	0.01

Protia's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(102.534	+	118.933)	/	26207.201
	=	0.01

Protia (XKRX:303360) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Protia Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Protia's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Protia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room 702, Building A, 401 Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07528

Website

http://www.protia.co.kr

Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,' as well as various immunochemical in vitro diagnostic products.

Protia Headlines

No Headlines